ANEST IWATA Corporation
September 18, 2026: Overview of the effectiveness evaluation results of the company’s board of directors
Publication of the board effectiveness evaluation results. Conducted using a third-party anonymous survey, evaluated across components including structure/operation, business strategy/plans, risk management, nominates and compensation, and shareholder dialogue. From FY2026 onward, improvement themes include revising the executive compensation structure, developing and implementing a succession plan for leadership, and strengthening stakeholder dialogue including external directors.
Key Figures
- 重要数値1: 実施期間は2026年4月〜2026年3月（評価対象）
- 重要数値2: 対象者は取締役計9名
- 重要数値3: 意見交換会は2026年6月〜8月に実施
AI要約
Overview of the Evaluation
This report presents an outline of the results of the board effectiveness evaluation conducted in FY2025. It follows anonymous surveys prepared by a third-party organization and discussions among directors, comprehensively evaluating board composition and governance, business strategy and plans, risk management, nomination and remuneration, and dialogue with shareholders and others. The evaluation indicates ongoing improvements, but concludes that further enhancements are needed in areas such as deliberation on key themes, shareholder dialogue framework, and monitoring progress of the current mid-term management plan.
Future Initiatives
In addition to enhancing comprehensive deliberations on mid- to long-term strategies such as DX/AI utilization, sustainability, talent development and retention, capital allocation, and business portfolio, we will strengthen our dialogue framework with external directors and shareholders, and ensure that the content and outcomes are reflected in the board. Specific measures will be considered through pre-meeting issue analysis, enhanced materials, and securing sufficient deliberation time, integrated into the annual plan.
Anest Iwata Corporation
Company overview · Stock price · Financial data · All IR
